Ads
related to: molecular gaze sculpture therapy for cancer cells impact factor
Search results
Results From The WOW.Com Content Network
In 2004, Suzanne Anker and Dorothy Nelkin's The Molecular Gaze also helped establish the integration of molecular biology with artistic practice. [27] [28] In 2015-2016 Amy Karle created Regenerative Reliquary, a sculpture of bio-printed scaffolds for human MSC stem cell culture into bone, in the shape of a human hand form installed in a vessel.
Cancer Cell is internationally regarded as one of the top cancer research and oncology journals. According to the Journal Citation Reports, the 2022 impact factor of the journal is 50.3. It is part of the Cell Press portfolio, which is owned by Elsevier. Issues are published monthly in print and online versions.
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research. The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research . [ 1 ]
Molecular Oncology is a monthly peer-reviewed open-access medical journal covering research in molecular oncology. It is published by Wiley on behalf of the Federation of European Biochemical Societies. The journal regularly publishes thematic issues with review articles focusing on specific topics of basic, translational, or clinical cancer ...
As a form of molecular medicine, targeted therapy blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, [2] rather than by simply interfering with all rapidly dividing cells (e.g. with traditional chemotherapy).
Cancer Cell International is an open-access, online-only journal which publishes articles focused on cancer cell. [2] Journal publishes also articles on cancer studies with the data from experiments. Publish research articles based on data in many fields, from cell proliferation to apoptosis, etc. [3]
Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. [1] Areas covered include molecular biology, cell biology, systems biology, stem cells, developmental biology, genetics and genomics, proteomics, cancer research, immunology, neuroscience, structural biology, microbiology, virology, physiology, biophysics, and ...
The Chinese Journal of Cancer (Chinese: 《癌症》) is a monthly peer-reviewed open access medical journal covering oncology. The editor-in-chief is Rui-Hua Xu of the Sun Yat-sen University Cancer Center. It is published by BioMed Central and sponsored by the Sun Yat-sen University Cancer Center. The journal was established in 1982.